Zeneca Casodex Clinical Trial Excerpts Cited In FDA Warning Letter
Zeneca's distribution of three leaflets excerpting clinical trial results for the prostate cancer therapy Casodex (bicalutamide) for off-label uses is among promotional activities by the company challenged in a Nov. 24 warning letter.
You may also be interested in...
FDA has increased from two to four weeks the time it takes to return direct-to-consumer broadcast ads with advisory comments due to the enlarged volume of submissions, Division of Drug Marketing, Advertising & Communications Branch Chief Nancy Ostrove, PhD, reported Sept. 13 at a Food & Drug Law Institute conference on "Marketing and Promotion in the New Millennium."
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011